Marseille-Kliniken AG

EANS-Adhoc: Marseille-Kliniken AG: Contract with Chairman Michael Thanheiser prolonged until 31 March 2017

--------------------------------------------------------------------------------
  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
Contracts

01.10.2012

Hamburg, 01 October 2012 - Marseille-Kliniken AG (Prime Standard, ISIN
DE0007783003, MKA) has prematurely prolonged the contract with Michael
Thanheiser as Chairman until 31 03 2017.

By the decision for early prolongation of the contract with Michael Thanheiser,
the supervisory board honoured the work performed by Mr. Thanheiser.

end of ad-hoc-announcement
================================================================================
About Marseille-Kliniken AG:

Marseille-Kliniken AG (ISIN DE0007783003, WKN 778300, MKA) with its 57
residential care facilities, three residential units for assisted living and
about 4,700 employees is a market leading listed company on health care in
Germany. The business model is significantly influenced by the demographic
development. Therefore Marseille-Kliniken AG has a secured future. Short-term
economic fluctuations on the other hand exert only a minor influence. As a
consistently modern company with strong focus on quality, the private enterprise
is in a good position within a competitive environment primarily characterized
by regionally active charities.

Further inquiry note:
Hillermann Consulting
Jan Pahl
Investor Relations for Marseille-Kliniken AG
Poststraße 14-16
20354 Hamburg
Germany
Tel.: +49 - (0)40 / 3202791-0
www.marseille-kliniken.de

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


issuer:      Marseille-Kliniken AG
             Alte Jakobstraße 79/80
             D-10179 Berlin
phone:       +49 (0)30 246 32-400
FAX:         +49 (0)30 246 32-401
mail:     info@marseille-kliniken.de
WWW:      http://www.marseille-kliniken.de
sector:      Pharmaceuticals
ISIN:        DE0007783003
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Düsseldorf, Stuttgart, regulated dealing:
             Hamburg, regulated dealing/prime standard: Frankfurt 
language:   English
 



Das könnte Sie auch interessieren: